ArticleNature2026
Parity and lactation induce T-cell-mediated breast cancer protection.
Abstract read
In one paragraph
Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- The immunology of human breast cancer.Nature reviews. Immunology · 2026Review
- Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications.The Journal of clinical investigation · 2026Review
- Article
- Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.Annals of oncology : official journal of the European Society for Medical Oncology · 2026Article
- Motherhood's immune legacy reshapes the breast for lasting cancer defence.Immuno-oncology technology · 2026Article
- Menopausal timing and senescent-immune coupling in age-related lobular involution of the human breast: a longitudinal cohort study.EBioMedicine · 2026Article
- Pregnancy-induced tissue-resident memory-like T cells contribute to tumor control in breast cancer.Nature immunology · 2026Article
- Prevalence, duration and factors associated with breastfeeding in French Guiana in 2024.International breastfeeding journal · 2026Article
- Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer.NPJ breast cancer · 2026Article
- Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study.Breast cancer research : BCR · 2026Article
- Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND study.Breast cancer research and treatment · 2026Article
- Glucocorticoids combined with anticoagulation modulate the central NLRP3/NETosis inflammatory process in patients with severe cerebral venous thrombosis: a human mechanistic exploratory study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
- Myeloperoxidase: one enzyme, two jobs.Cell research · 2026Article
- LifelongNutrients · 2026Article
- Motherhood Imprints Tissue-Resident CD8Research (Washington, D.C.) · 2026Article
- Triple-negative breast cancer, pregnancy, and HLA alloreactivity: a cause for concern?Frontiers in oncology · 2026Article
- Functional shifts in immune composition follow lactation stage in human milk.Frontiers in immunology · 2026Article
- Does ovarian stimulation accelerate the progression of BI-RADS categories? a propensity score matching-based retrospective cohort study.Frontiers in endocrinology · 2026Article
- Tissue-resident memory T cells reshapeFrontiers in immunology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Balaji Virassamy *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-7341-8104
Franco Caramia *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Peter Savas *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0001-5999-428X
Michael A Harris *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-9904-4091
Jia-Wern PanCancer Research Malaysia, Subang Jaya, Malaysia.ORCID 0000-0003-0875-9831
Jianan WangDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-5213-8330
Emmaline BrownDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Megan M R O'MalleyDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Courtney T van GeelenDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-2716-9135
Michael HunDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Thomas N BurnDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0003-1763-1418
Sneha SantDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Jamieson D BallanDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0009-0008-9011-914X
Jasmine KayDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0009-0009-6673-6604
Luis E Lara GonzalezDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0003-3897-353X
Kylie ClarkeDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Han Xian Aw YeangDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-1705-692X
Rejhan IdriziDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Metta JanaDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0001-7092-045X
Damon J ChalliceDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Roberto SalgadoDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-1110-3801
Heather ThorneDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
kConFab consortium
Cathie PolinessDepartment of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sophie NightingaleDepartment of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Soo-Hwang TeoCancer Research Malaysia, Subang Jaya, Malaysia.
Terence P SpeedBioinformatics and Computational Biology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.ORCID 0000-0002-5403-7998
Jane VisvaderCancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.ORCID 0000-0001-9173-6977
Paul J NeesonDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-2729-5887
Phillip K DarcyDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-5303-9561
Laura K MackayDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. lkmackay@unimelb.edu.au.ORCID 0000-0002-8496-6632
Sherene LoiDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. sherene.loi@petermac.org.ORCID 0000-0001-6137-9171
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parity and breastfeeding reduce the risk of breast cancer, particularly triple-negative breast cancer (TNBC)
Indexed as
Breast NeoplasmsCD8-Positive T-LymphocytesLactationParityTriple Negative Breast NeoplasmsAdultAnimalsDisease Models, AnimalFemaleHumansImmunologic MemoryMicePregnancy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.